Your browser doesn't support javascript.
loading
The role of therapy in the outcome of patients with myelofibrosis.
Masarova, Lucia; Bose, Prithviraj; Pemmaraju, Naveen; Daver, Naval G; Sasaki, Koji; Chifotides, Helen T; Zhou, Lingsha; Kantarjian, Hagop M; Estrov, Zeev; Verstovsek, Srdan.
  • Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chifotides HT; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhou L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer ; 129(18): 2828-2835, 2023 09 15.
Article en En | MEDLINE | ID: mdl-37243913

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Inhibidores de las Cinasas Janus Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Inhibidores de las Cinasas Janus Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article